Loading...

Getinge AB (publ)

GNGBFPNK
Healthcare
Medical - Devices
$21.00
$0.00(0.00%)

Getinge AB (publ) (GNGBF) Financial Performance & Income Statement Overview

Explore the financials of Getinge AB (publ) (GNGBF), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
9.21%
9.21%
Operating Income Growth
-23.61%
23.61%
Net Income Growth
-32.09%
32.09%
Operating Cash Flow Growth
54.79%
54.79%
Operating Margin
7.70%
7.70%
Gross Margin
46.89%
46.89%
Net Profit Margin
4.20%
4.20%
ROE
4.86%
4.86%
ROIC
6.28%
6.28%

Getinge AB (publ) (GNGBF) Income Statement & Financial Overview

Explore comprehensive income reports for Getinge AB (publ) GNGBF, broken down by year and quarter.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$8.32B$11.07B$7.87B$8.30B
Cost of Revenue$4.22B$6.02B$4.32B$4.65B
Gross Profit$4.09B$5.05B$3.56B$3.66B
Gross Profit Ratio$0.49$0.46$0.45$0.44
R&D Expenses$318.00M$446.00M$319.00M$338.00M
SG&A Expenses$2.77B$2.96B$2.46B$2.65B
Operating Expenses$3.50B$3.97B$3.37B$2.75B
Total Costs & Expenses$7.72B$9.99B$7.69B$7.40B
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$152.00M$130.00M
Depreciation & Amortization$566.00M$935.00M$522.00M$493.00M
EBITDA$1.46B$2.64B$861.00M$1.40B
EBITDA Ratio$0.18$0.24$0.11$0.17
Operating Income$598.00M$1.08B$184.00M$906.00M
Operating Income Ratio$0.07$0.10$0.02$0.11
Other Income/Expenses (Net)-$170.00M-$173.00M-$152.00M-$130.00M
Income Before Tax$428.00M$911.00M$32.00M$700.00M
Income Before Tax Ratio$0.05$0.08$0.004$0.08
Income Tax Expense$124.00M$243.00M$23.00M$187.00M
Net Income$300.00M$664.00M$2.00M$513.00M
Net Income Ratio$0.04$0.06$0.00$0.06
EPS$1.10$2.44$0.007$1.88
Diluted EPS$1.10$2.44$0.007$1.88
Weighted Avg Shares Outstanding$272.37M$272.37M$272.37M$272.37M
Weighted Avg Shares Outstanding (Diluted)$272.37M$272.37M$272.37M$272.37M

Over the last four quarters, Getinge AB (publ) achieved steady financial progress, growing revenue from $8.30B in Q2 2024 to $8.32B in Q1 2025. Gross profit stayed firm with margins at 49% in Q1 2025 versus 44% in Q2 2024. Operating income totaled $598.00M in Q1 2025, maintaining a 7% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $1.46B. Net income dropped to $300.00M, with EPS at $1.10. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;